![Enno Spillner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enno Spillner
Direttore Finanziario/CFO presso
FORMYCON AG
Patrimonio netto: 158 892 $ in data 31/05/2026
Profilo
Attualmente, Enno Spillner ricopre la posizione di Chief Financial Officer per Evotec SE e Co-Managing Director presso Evotec International GmbH (una filiale di Evotec SE). È anche nel consiglio di amministrazione di Nanobiotix SA e Concentro Management AG e Managing Partner di Biom Venture Capital GmbH & Co. Fonds KG. Nella sua carriera passata il signor Spillner ha occupato la posizione di Chief Executive & Financial Officer di 4SC AG, Managing Director di Munich Innovative Biomaterials GmbH, Managing Director di ActiPac Biosystems GmbH e Head-Finance & Controlling di BioM AG Munich BioTech Development. Enno Spillner ha ricevuto un MBA dall'Università di Bamberg.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NANOBIOTIX SA 0,01% | 31/03/2026 | 4.000 ( 0,01% ) | 158 892 $ | 31/05/2026 |
Posizioni attive di Enno Spillner
| Società | Posizione | Inizio |
|---|---|---|
| NANOBIOTIX | Direttore/Membro del Consiglio | 18/06/2014 |
| FORMYCON AG | Direttore Finanziario/CFO | 01/04/2023 |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Provides financial consulting services | Direttore/Membro del Consiglio | 11/05/2010 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Direttore/Membro del Consiglio | - |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Direttore/Membro del Consiglio | 01/01/2014 |
Precedenti posizioni note di Enno Spillner
| Società | Posizione | Fine |
|---|---|---|
| EVOTEC SE | Direttore Finanziario/CFO | 01/03/2023 |
| 4SC AG | Amministratore Delegato | 30/06/2016 |
ActiPac Biosystems GmbH | Amministratore Delegato | 01/03/2000 |
Munich Innovative Biomaterials GmbH
 Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Amministratore Delegato | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
Formazione di Enno Spillner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
41
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Finance |
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Finance |
University of Bamberg
 University of Bamberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biom Venture Capital GmbH & Co. Fonds KG
 Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Provides financial consulting services | Finance |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Finance |
